Pharmaceutical Supply – Trazodone Tablets (50 mg)

The contract calls for the manufacture, packaging, and supply of Trazodone Hydrochloride 50 mg tablets to meet stringent regulatory and military specifications, including compliance with FDA regulations, Department of Defense Logistics Agency requirements, and current Good Manufacturing Practices. Production must adhere to ASTM D3951 for packaging and MIL-STD-129 for military labeling and documentation, ensuring full traceability and readiness for federal use. The product is intended for distribution through the Department of Defense’s medical supply chain, requiring rigorous quality control and consistent batch integrity throughout all stages of production and packaging. Subcontractors must respond by May 19, 2026, under solicitation SPE2DP26T3391, with all work aligned to NAICS code 325412 for pharmaceutical preparation manufacturing. The contract is managed by the Medical Supply Chain Pharm FSA within the Department of Defense, and performance is expected to support military healthcare operations without geographic restriction. While specific delivery locations and point of contact details are not provided, full compliance with defense logistics standards is mandatory, and all packaging must be formatted for seamless integration into military inventory and distribution systems.